iSpecimen Inc. (NASDAQ:ISPC) Short Interest Update

iSpecimen Inc. (NASDAQ:ISPC) was the target of a large drop in short interest in August. As of August 31st, there was short interest totalling 326,400 shares, a drop of 8.3% from the August 15th total of 355,900 shares. Approximately 3.2% of the company’s stock are short sold. Based on an average daily volume of 1,970,000 shares, the short-interest ratio is currently 0.2 days.

iSpecimen Price Performance

iSpecimen stock opened at $5.52 on Thursday. iSpecimen has a 12-month low of $3.41 and a 12-month high of $15.38. The firm’s fifty day moving average price is $0.56 and its 200 day moving average price is $0.40. The company has a market capitalization of $72.17 million, a price-to-earnings ratio of -4.31 and a beta of 1.60.

iSpecimen (NASDAQ:ISPC) last released its quarterly earnings results on Tuesday, August 6th. The company reported ($0.19) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.28) by $0.09. The business had revenue of $2.86 million during the quarter. iSpecimen had a negative net margin of 97.03% and a negative return on equity of 115.36%.

About iSpecimen

iSpecimen Inc provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers.